Regentatlantic Capital LLC Bio Rad Laboratories, Inc. Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 1,999 shares of BIO stock, worth $668,825. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,999

Previous 2,106 5.08%

Holding current value

$668,825

Previous $1.04 Million 19.96%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $44,147 - $60,268	-107 Reduced 5.08%	1,999 $834,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $21,792 - $28,066	-47 Reduced 2.18%	2,106 $1.04 Million
Q1 2022 May 02, 2022	SELL	$524.57 - $735.42 $33,047 - $46,331	-63 Reduced 2.84%	2,153 $1.21 Million
Q4 2021 Jan 27, 2022	SELL	$708.84 - $794.68 $51,036 - $57,216	-72 Reduced 3.15%	2,216 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $134,172 - $168,457	-204 Reduced 8.19%	2,288 $1.71 Million
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $63,430 - $71,394	-110 Reduced 4.23%	2,492 $1.61 Million
Q1 2021 Apr 29, 2021	SELL	$547.01 - $662.35 $116,513 - $141,080	-213 Reduced 7.57%	2,602 $1.49 Million
Q4 2020 Feb 04, 2021	SELL	$510.68 - $643.45 $26,555 - $33,459	-52 Reduced 1.81%	2,815 $2,000
Q3 2020 Oct 13, 2020	BUY	$454.43 - $535.6 $11,815 - $13,925	26 Added 0.92%	2,867 $1.48 Million
Q2 2020 Aug 13, 2020	BUY	$334.87 - $493.06 $74,676 - $109,952	223 Added 8.52%	2,841 $1.28 Million
Q1 2020 May 14, 2020	BUY	$320.01 - $409.07 $101,443 - $129,675	317 Added 13.78%	2,618 $918,000
Q4 2019 Feb 04, 2020	BUY	$319.73 - $374.2 $130,449 - $152,673	408 Added 21.55%	2,301 $851,000
Q3 2019 Oct 22, 2019	SELL	$304.55 - $345.24 $23,450 - $26,583	-77 Reduced 3.91%	1,893 $630,000
Q2 2019 Jul 23, 2019	SELL	$286.93 - $312.59 $9,468 - $10,315	-33 Reduced 1.65%	1,970 $616,000
Q1 2019 May 03, 2019	BUY	$224.3 - $317.41 $2,691 - $3,808	12 Added 0.6%	2,003 $612,000
Q4 2018 Jan 30, 2019	BUY	$220.1 - $309.0 $282,388 - $396,447	1,283 Added 181.21%	1,991 $462,000
Q3 2018 Oct 30, 2018	BUY	$289.28 - $326.15 $204,810 - $230,914	708 New	708 $222,000

Others Institutions Holding BIO

# of Institutions

461

Shares Held

19.6M

Call Options Held

23.2K

Put Options Held

37.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.24B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Bio Rad Laboratories, Inc. Transaction History